Indian Journal of Endocrinology and Metabolism

REVIEW ARTICLE
Year
: 2012  |  Volume : 16  |  Issue : 3  |  Page : 381--383

Oral manifestations in growth hormone disorders


Gaurav Atreja1, Shikha Handa Atreja2, Nitul Jain3, Urvashi Sukhija1,  
1 Department of Prosthodontics, MMCDSR, Mullana, Haryana, India
2 Department of Pediatric Dentistry, MMCDSR, Mullana, Haryana, India
3 Department of Oral Pathology, EDCH, Kotputli, Rajasthan, India

Correspondence Address:
Gaurav Atreja
Department of Prosthodontics, MMCDSR, Mullana, Haryana
India

Abstract

Growth hormone is of vital importance for normal growth and development. Individuals with growth hormone deficiency develop pituitary dwarfism with disproportionate delayed growth of skull and facial skeleton giving them a small facial appearance for their age. Both hyper and hypopituitarism have a marked effect on development of oro-facial structures including eruption and shedding patterns of teeth, thus giving an opportunity to treating dental professionals to first see the signs and symptoms of these growth disorders and correctly diagnose the serious underlying disease.



How to cite this article:
Atreja G, Atreja SH, Jain N, Sukhija U. Oral manifestations in growth hormone disorders.Indian J Endocr Metab 2012;16:381-383


How to cite this URL:
Atreja G, Atreja SH, Jain N, Sukhija U. Oral manifestations in growth hormone disorders. Indian J Endocr Metab [serial online] 2012 [cited 2019 Sep 22 ];16:381-383
Available from: http://www.ijem.in/text.asp?2012/16/3/381/95678


Full Text

 Introduction



Growth hormone (GH) hypersecretion results in gigantism or acromegaly, a condition associated with significant morbidity and mortality, while GH deficiency results in dwarfism, growth retardation in children, and the GH-deficiency syndrome in adults.

This article aims at reviewing the various oro-facial and dental manifestations seen in pituitary gland disorder and highlights the need to diagnose such changes as earlier as possible so as to avoid associated medical complications and to reduce mortality and morbidity.

[Table 1] highlights the important oro-facial and dental changes as observed in pituitary dwarfism, gigantism, and acromegaly{Table 1}

 Hypopituitarism



The most striking feature of pituitary dwarfism is short stature of the affected patient and the low growth velocity for age. The maxilla and mandible of affected patients are smaller than the normal and the face appears smaller [1],[2],[3],[4] with the permanent teeth showing a delayed pattern of eruption. [3],[5] Often the shedding pattern of deciduous teeth is delayed by several years, and also the development of roots of permanent teeth appears to be delayed. The dental arches are smaller than the normal and therefore cannot accommodate all the teeth resulting in dental malocclusion. The complete absence of buds of the wisdom tooth even in the patient in fourth decade of life is also reported. [3],[4] Other rare findings such as agenesis of the upper central incisor and solitary maxillary central incisor have been observed. [6],[7] Amelogenesis imperfecta a diverse group of hereditary disorder that is characterized by defect in formation of tooth enamel has also been seen in the patient with reduced amount of growth hormone. [8]

In adult hypopituitarism, changes in the head include thin eye brows, loss of eyelashes, sharp features, thin lips, and immobile expression. No specific dental changes have been described in this condition. [1]

 Hyperpituitarism



Gigantism and oral manifestations

Gigantism is the childhood version of growth hormone excess and is characterized by the general symmetrical overgrowth of the body parts. [2] Prognathic mandible, frontal bossing, dental malocclusion, and interdental spacing are the other features which may be seen in such individuals. Intraoral radiograph may show hypercementosis of the roots. [1]

Acromegaly and oral manifestations

Acromegaly is characterized by an acquired progressive somatic disfigurement, mainly involving the face and extremities, but also many other organs, that are associated with systemic manifestations. [9] The most typical clinical signs are the coarse facial features, large, spade shaped hands, and enlarged feet resulting from soft tissue swelling and bony enlargement.

This rare systemic disease induces changes in various vital organs. Among them is a change in occlusion that can bring the patient to the dentist first. Dental professionals may be the first healthcare providers to see the signs. [10]

Craniofacial changes are characteristic of this disease and may involve facial skin, extraoral and intraoral soft and hard tissues. [11] Thickening of the skin is due to deposition of glycosaminoglycan and increased collagen synthesis by the connective tissue. [9] The lips become thick and negroid. [1],[12] The most characteristic craniofacial skeletal differences are protruded glabella and increased anterior face height. Mandibular prognathism and jaw thickening are due to deposition of periosteal bone in response to the excess growth hormone. [9]

Other intraoral changes are spacing in the teeth, [12],[13] malocclusion, aperthognathia, [14],[15] macroglossia, hypertrophy of palatal tissues which may cause or accentuate sleep apnea, [12] buccal tipping of the teeth due to enlarged tongue. [1] Dental radiograph may demonstrate large pulp chambers (taurodontism) and excessive deposition of cementum on the roots. According to the morphologic analysis study conducted in Japan, male patients tended to demonstrate downward mandibular advancement and crossbite, while females showed extension of the ascending ramus, downward displacement of mandible, bimaxillary alveolar protrusion, and edge-to-edge bite. [16] The disease also has rheumatologic, cardiovascular, respiratory, and metabolic consequences which determine its prognosis.

Complications associated with hyperpituitarism

These oral manifestations of hyperpituitarism may give clues to underlying serious systemic problems, complications of which may include cardio-vascular complications like concentric biventricular hypertrophy or heart failures or respiratory complications like sleep apnea. Metabolic complications include impaired glucose intolerance due to growth hormone-induced insulin resistance and lipid abnormalities like hypertriglyceridemia. Muskuloskeletal complications and arthropathy along with other endocrinal disturbances including benign thyroid overgrowth, hypogonadism, and gonadal dysfunction may also be observed as associated complications. [17],[18]

 Role of Endocrinologist and Dentist



The oral cavity is an important anatomical location with a role in many critical physiologic processes, such as digestion, respiration, and speech. It is also unique for the presence of exposed hard tissue surrounded by mucosa. The mouth is frequently involved in conditions that affect the skin or other multiorgan diseases. In many instances, oral involvement precedes the appearance of other symptoms or lesions at other locations.

So it is very important for both endocrinologist and dentist to communicate with each other to order diagnostic tests, evaluate the results and create, administer and monitor treatment plans, and medications designed to address the problems.

 Conclusion



As changes in the oral cavity may be presenting symptoms of pituitary disease, the dental professional may be the first healthcare provider to come across such patients. Thus the dental professional may play an important role in diagnosing and treating such patients.

References

1Shafer GW, Hine MK, Levy BM, editors. Oral aspects of metabolic disease. A Textbook of Oral Pathology. 4 th ed. India: Harcourt Brace Asia Inc.; 1994. p. 654-7.
2Neville B, Damm DD, Allen MC, editors. Oral and maxillofacial pathology. 3 rd ed. India: Elsevier Inc.; 2010. p. 831-3.
3Kosowicz J, Rzymski K. Abnormalities of tooth development in pituitary dwarfism. Oral Surg Oral Med Oral Pathol 1977;44:853-63.
4Sarnat H, Kaplan I, Pertzelan A, Laron Z. Comparison of dental findings in patients with isolated growth hormone deficiency treated with human growth hormone (hGH) and in untreated patients with Laron-type dwarfism. Oral Surg Oral Med Oral Pathol 1988;66:581-6.
5Bigeard L, Sommermater J. Dental delay and microdontia in children with somatotropin hormone deficiency. J Biol Buccale 1991;19:291-6.
6Bretéché F, Delaire J, Ginguene Y. Agenesis of the superior central incisor. Its relation to pituitary nanism. Rev Stomatol Chir Maxillofac 1984;85:72-4.
7Lo FS, Lee YJ, Lin SP, Shen EY, Huang JK, Lee KS. Solitary maxillary central incisor and congenital nasal pyriform aperture stenosis. Eur J Pediatr 1998;157:39-44.
8Parentin F, Perissutti P. Solitary median maxillary central incisor, Duane retraction syndrome, growth hormone deficiency and duplicated thumb phalanx: A case report. Clin Dysmorphol 2003;12:141-2.
9Chanson P, Salenave S. Acromegaly. Orphanet J Rare Dis 2008;3:17.
10Sarment DP, Weisgold AS. The importance of dentistry in the differential diagnosis of a medical disorder. Compend Contin Educ Dent 1998;19:124-6, 128-9.
11Ezzat S, Forster MJ, Berchtold P, Redelmeier DA, Boerlin V, Harris AG. Acromegaly. Clinical and biochemical features in 500 patients. Medicine (Baltimore) 1994;73:233-40.
12Silvertone FS. Endocrine Disease. In: Greenberg SM, Glick M, Ship JA. editors. Burket's Oral medicine. 11 th ed. BC Decker Inc; India. 2007. p. 521-4.
13Lima DL, Montenegro RM Jr, Vieira AP, Albano MF, Rego DM. Absence of periodontitis in acromegalic patients. Clin Oral Investig 2009;13:165-9.
14Cohen RB, Wilcox CW. A case of acromegaly identified after patient complaint of apertognathia. Oral Surg Oral Med Oral Pathol 1993;75:583-6.
15Sugata T, Myoken Y, Tanaka S. Acromegaly identified in a patient with a complaint of malocclusion. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;85:44-6.
16Takakura M, Kuroda T. Morphologic analysis of dentofacial structure in patients with acromegaly. Int J Adult Orthodon Orthognath Surg 1998;13:277-88.
17Ayuk J, Sheppard MC. Growth hormone and its disorders. Postgrad Med J 2006;82:24-30.
18Nabarro JD. Acromegaly. Clin Endocrinol (Oxf) 1987;26:481-512.